This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Molecular Targeting Technologies, Inc. (MTTI), a small disadvantaged business. The $222,581 firm fixed-price contract supports the development of target-specific molecular imaging agents to be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This SBIR contract falls under Topic 85 and is set...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...
This is a $1,725,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The contract is for the development of targeted molecular imaging agents to detect high-risk atherosclerotic plaque, in combination with existing imaging modalities. Ocean Nano TECH LLC is a nanotechnology...
This federal contract award of $224,973 was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Nanohybrids Inc., a for-profit company. The contract is for the development of target-specific molecular imaging agents to detect high-risk atherosclerotic plaque, under the Small Business Innovation Research (SBIR) program. The contract is a Definitive Contract, Firm Fixed Price type, with a completion date of September 7, 2015. There is no set-aside designation...
This is a $1,591,490.86 Firm Fixed Price SBIR Phase I contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency, to Collagen Medical LLC, a for-profit limited liability company, to support the development of target-specific molecular imaging agents in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. The contract is set aside for small businesses. Collagen Medical has previously received federal grants from the National...
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health awarded a $256,870.96 Firm Fixed Price contract to Sigt LLC, a for-profit limited liability company, for the development of an "Active MRI Transseptal Needle" under the Small Business Innovation Research (SBIR) program. This Phase I contract supports the prototyping and proof-of-concept testing of Sigt LLC's proprietary "High Frequency Dielectric Sensing" technology, which enables...
<p>This is a federal contract award from the National Heart Lung and Blood Institute, a civilian agency, to Biomedomics, Inc., a minority-owned, for-profit manufacturer of goods, for a Small Business Innovation Research (SBIR) Program Phase I research project. The contract has a Firm Fixed Price of $99,932.00 and was awarded on December 1, 2009 with a completion date of May 31, 2010. The contract is set aside for small businesses. No additional subcontractors or context are provided.</p>
This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
This federal contract award, identified as HHSN268201200064C, was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to HDL Apomics LLC, a small business. The $139,291.00 Firm Fixed Price contract is for "OTHER FUNCTIONS-ANTIBODY PROTEOMICS FOR MEASURING LIPOPROTEIN SUB-POPULATIONS" under the SBIR TOPIC 64 PHASE 1 - NOVEL TECHNOLOGIES FOR ASSESSING LIPOPROTEIN SUB-FRACTIONS program. The contract has a total small business set-aside...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research is being conducted under a Definitive Contract with a Firm Fixed Price pricing type.